Caring for a patient with a known history of alcohol use disorder requires vigilance across several fronts at once: monitoring for withdrawal, protecting against nutritional deficits that can cause permanent brain damage, watching for liver-related complications, and communicating in a way that builds trust rather than resistance. The challenge is that these needs often overlap and escalate quickly, sometimes within hours of the patient’s last drink.
Withdrawal Can Begin Within Hours
Alcohol withdrawal follows a fairly predictable timeline, and knowing it helps you stay ahead of dangerous complications. The first symptom is typically tremor, which can appear within six hours of the patient’s last drink. Hallucinations may follow between 12 and 24 hours. Seizures can emerge any time after 24 hours and are usually generalized (affecting the whole body). The most dangerous stage, delirium tremens, typically develops 48 to 72 hours after cessation.
Delirium tremens sits at the most severe end of the withdrawal spectrum and can be fatal without prompt treatment. It’s characterized by a rapid onset of confusion with a fluctuating course, disturbed consciousness, abnormal psychomotor activity, and disrupted sleep-wake cycles. Not every patient will progress to this stage, but anyone with a history of heavy, prolonged drinking is at risk.
The key vital sign changes to watch for during withdrawal include a systolic blood pressure at or above 160, diastolic at or above 90, heart rate at or above 90, visible tremor, sweating, and agitation. These are scored together to guide treatment decisions. Patients with a history of withdrawal seizures need especially close monitoring because seizures can occur even without obvious autonomic symptoms beforehand.
Environmental and Seizure Safety
Patients in alcohol withdrawal should be placed in a quiet room with low lighting and minimal stimulation. This is not just a comfort measure. Sensory overload can worsen agitation, raise blood pressure, and lower the seizure threshold. If a patient has active seizures or is progressing toward delirium tremens, intravenous access should be established immediately for fluid and medication delivery.
Any patient who presents with seizures after stopping alcohol, regardless of whether they’ve had them before, should ideally be monitored as an inpatient for at least 36 to 48 hours. This window covers the period of highest risk for additional seizures or progression to delirium tremens. Physical restraints may be needed in cases of severe agitation to prevent self-injury, but adequate sedation is the first-line approach to calming the patient.
Thiamine Before Glucose
Chronic alcohol use depletes thiamine (vitamin B1), and this deficiency can cause Wernicke’s encephalopathy, a brain condition marked by confusion, eye movement abnormalities, and unsteady gait. Left untreated, it can progress to Korsakoff syndrome, which involves permanent, severe memory loss. This is one of the most preventable catastrophes in medicine, and the prevention is simple: give thiamine early.
For patients considered at risk but not yet showing symptoms, guidelines from the Royal College of Physicians recommend 250 mg of intravenous thiamine once daily for three to five days. For patients with suspected symptoms, the recommended dose jumps to 500 mg three times daily for the same duration. The critical rule is that thiamine must be given before any glucose-containing fluids. Glucose metabolism burns through the body’s remaining thiamine stores, and administering sugar first can actually trigger or worsen the encephalopathy you’re trying to prevent.
Electrolyte Deficits That Compound the Risk
Chronic alcohol use disrupts levels of magnesium, potassium, phosphate, sodium, and calcium. These imbalances persist even during withdrawal and can create problems that mimic or worsen withdrawal symptoms. Low magnesium is particularly dangerous because it causes a cascade of other deficits: it triggers potassium wasting through the kidneys, lowers calcium levels by impairing parathyroid hormone function, and on its own can cause tremor, seizures, muscle weakness, cardiac arrhythmias, and psychiatric symptoms including depression and psychosis.
Low phosphate levels are also common in this population and can contribute to muscle weakness and altered mental status. The practical takeaway is that electrolyte panels should be checked early and corrected aggressively. Replacing magnesium in particular can make potassium and calcium correction far more effective, since the body struggles to hold onto those minerals when magnesium is depleted.
Assessing for Liver-Related Cognitive Changes
Patients with a history of heavy alcohol use may have underlying liver damage that affects brain function. Hepatic encephalopathy occurs when a damaged liver can no longer clear toxins (primarily ammonia) from the blood, and those toxins impair cognition. This can look like confusion, impaired alertness, or personality changes, symptoms that overlap significantly with withdrawal and can easily be misattributed.
One physical sign that helps distinguish liver-related encephalopathy is asterixis, sometimes called “liver flap.” It’s a sudden, involuntary jerking movement of the hands caused by brief lapses in muscle tone. You can test for it by asking the patient to hold their hands out with wrists extended (as if pushing against a wall). In a positive test, the hands will make irregular flapping or dropping movements. Asterixis is usually asymptomatic, meaning patients won’t report it on their own. Actively checking for it in any confused patient with a drinking history can reveal an underlying metabolic cause that needs its own treatment path.
Communication That Builds Trust
Patients with alcohol use disorder frequently encounter judgment in healthcare settings, and many have learned to be guarded or evasive as a result. Motivational interviewing is a communication approach built around four principles: expressing empathy, supporting self-efficacy, rolling with resistance, and developing discrepancy. In practice, this means seeing the situation through the patient’s eyes rather than lecturing, letting the patient take ownership of any decisions about change, and never directly fighting their resistance.
When a patient pushes back or minimizes their drinking, the instinct is to confront them with evidence. Motivational interviewing takes the opposite approach: you use the patient’s own momentum to explore their views further. Instead of arguing, you might ask what they see as the connection between their drinking and the health problem that brought them in. The goal is to help the patient notice the gap between where they are now and where they want to be. This isn’t a one-time technique. Even brief conversations structured this way, sometimes just a few minutes during routine care, can shift a patient’s thinking over time.
Medications for Long-Term Recovery
Three medications are approved for treating alcohol use disorder, and patients may be started on one during or after their acute care. Naltrexone works by blocking the brain’s opioid receptors, which are responsible for the pleasurable effects of drinking. When those receptors are blocked, alcohol produces less euphoria and cravings diminish. It’s available as a daily pill or a monthly injection. Acamprosate helps stabilize brain chemistry that becomes disrupted after prolonged heavy drinking, reducing the discomfort and anxiety that often trigger relapse. Disulfiram takes a different approach entirely: it causes nausea, flushing, and other unpleasant symptoms if the patient drinks, creating a strong physical deterrent.
Knowing which medication a patient is on matters for their care. A patient on disulfiram who is inadvertently exposed to alcohol (including in some medications, mouthwashes, or food preparations) can have a significant reaction. A patient on naltrexone will not respond normally to opioid pain medications, which has obvious implications if they need acute pain management.
Psychiatric Overlap Is the Rule, Not the Exception
Depression and anxiety disorders co-occur with alcohol use disorder at very high rates. This creates a clinical puzzle: alcohol withdrawal itself causes anxiety, insomnia, and depressed mood, so it can be difficult to tell whether psychiatric symptoms are independent conditions or withdrawal effects. The general approach is to stabilize the patient through acute withdrawal first and then reassess. Symptoms that persist beyond two to four weeks of sobriety are more likely to represent a standalone psychiatric condition that needs its own treatment.
In the meantime, it’s important not to dismiss a patient’s emotional distress as “just withdrawal.” Suicidal ideation can occur during withdrawal, and the combination of impaired judgment, physical discomfort, and psychological distress makes this a genuinely high-risk period. Screening for safety should be part of routine care throughout the withdrawal process.